Celgene Germany

Last update: November 7, 2019

Pharmaceuticals
Germany Its 3 main executives

Recent executive movements at Bristol-Myers Squibb

Tim Power who is Lead, Investor Relations, will be promoted to Vice President and Head of Investor Relations on Mar. 31, 2020  (news posted on January 7 2020).
Kathryn Metcalfe has joined the company as Executive Vice President, Corporate Affairs  (news posted on January 7 2020).
John Elicker, Senior Vice President, Public Affairs and Investor Relations, will retire on Mar. 31, 2020  (news posted on January 7 2020).

Click here to view some more movements at Bristol-Myers Squibb

Create an alert
to follow the executive moves at Celgene Germany.

Latest M&A news in Pharmaceuticals.

Qualigen has announced the acquisition of Ritter Pharmaceuticals (posted on Jan 21, 2020).
Alexion Pharmaceuticals has announced the acquisition of Achillion Pharmaceuticals (posted on Dec 19, 2019).
Pfizer has announced the acquisition of Mylan (posted on Dec 19, 2019).

Latest news about Celgene Germany

Celgene Germany on Wikipedia, Google News & Yahoo Finance

Celgene Germany on LinkedIn, Twitter & YouTube

Celgene Germany has 1,979 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Sanofi (France). Celgene Germany is owned by Celgene EMEA.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.